Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1
暂无分享,去创建一个
Joseph Sodroski | J. Sodroski | Xinzhen Yang | Xinzhen Yang | Svetla Kurteva | Sandra Lee | S. Kurteva | Sandra Lee
[1] J. Hoxie,et al. The Stoichiometry of Trimeric SIV Glycoprotein Interaction with CD4 Differs from That of Anti-envelope Antibody Fab Fragments* , 2001, The Journal of Biological Chemistry.
[2] S. Zolla-Pazner,et al. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity. , 1997, Journal of immunology.
[3] William C. Olson,et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.
[4] J. Skehel,et al. Mechanism of neutralization of influenza virus infectivity by antibodies. , 2002, Virology.
[5] A. Trkola,et al. HIV type 1 coreceptors, neutralization serotypes, and vaccine development. , 1997, AIDS research and human retroviruses.
[6] E. Fenyö,et al. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization. , 1997, Virology.
[7] J. Sodroski,et al. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein , 1993, Journal of virology.
[8] A. Ishimoto,et al. Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1. , 2001, Virology.
[9] J. L. Raina,et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. , 1992, Virology.
[10] Abraham Pinter,et al. Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades , 2002, Journal of Virology.
[11] K. Reimann,et al. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses. , 1999, Virology.
[12] S. Durell,et al. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events , 1996, The Journal of cell biology.
[13] J. Bonifacino,et al. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[14] Bernhard Moser,et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.
[15] Gilcher Ro. Human retroviruses and AIDS. , 1988 .
[16] W. Koff,et al. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. , 2004, Science.
[17] Peter D. Kwong,et al. The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.
[18] A. Trkola,et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[19] J. Sodroski,et al. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.
[20] P. Earl,et al. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein , 1991, Journal of virology.
[21] N. Haigwood,et al. Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys , 1999, Nature Medicine.
[22] C. Cheng‐Mayer,et al. Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro , 2001, Journal of Virology.
[23] Q. Sattentau,et al. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.
[24] T. Brubaker,et al. Nonlinear Parameter Estimation , 1979 .
[25] P. Sharp,et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation , 1992, Journal of virology.
[26] K. Salzwedel,et al. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] Kenneth A. Taylor,et al. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Sodroski,et al. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. , 2000, AIDS research and human retroviruses.
[29] J. Moore,et al. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies , 1994, Journal of virology.
[30] P. Bugelski,et al. Morphometric analysis of envelope glycoprotein gp120 distribution on HIV-1 virions. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[31] T. Copeland,et al. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. , 1986, The Journal of general virology.
[32] J. Sodroski,et al. Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus , 1999, Journal of Virology.
[33] I. Jones,et al. Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin , 1993, Journal of virology.
[34] J. Mascola,et al. Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies , 1999, Journal of Virology.
[35] Q. Sattentau,et al. Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity , 1998, Journal of Virology.
[36] Robyn L Stanfield,et al. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. , 2004, Structure.
[37] J. Robinson,et al. Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Hoxie,et al. Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus , 2002, Journal of Virology.
[39] D R Burton,et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.
[40] J. Kappes,et al. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes , 1991, Journal of virology.
[41] A. Trkola,et al. Antibody Neutralization-Resistant Primary Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[42] D R Burton,et al. A model for neutralization of viruses based on antibody coating of the virion surface. , 2001, Current topics in microbiology and immunology.
[43] A. Trkola,et al. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG , 1995, Journal of virology.
[44] J. Sodroski,et al. Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus , 2000, Journal of Virology.
[45] S. Pelletier,et al. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers , 1996, The Journal of cell biology.
[46] N J Dimmock,et al. Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor. , 1994, Virology.
[47] J. Robinson,et al. Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines. , 1990, AIDS research and human retroviruses.
[48] H. Fleury,et al. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals , 1997, Journal of virology.
[49] R. Doms,et al. Modulation of Env Content in Virions of Simian Immunodeficiency Virus: Correlation with Cell Surface Expression and Virion Infectivity , 2004, Journal of Virology.
[50] N. Dimmock,et al. Quantitative relationships between an influenza virus and neutralizing antibody. , 1987, Virology.
[51] Hans Wolf,et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.
[52] L. Cavacini,et al. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. , 1993, Journal of acquired immune deficiency syndromes.
[53] G. Pauli,et al. The organization of the envelope projections on the surface of HIV , 2005, Archives of Virology.
[54] R. Webster,et al. Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers , 1988, The Journal of cell biology.
[55] Yonathan Bard,et al. Nonlinear parameter estimation , 1974 .
[56] Wayne C Koff,et al. HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.
[57] John P. Moore,et al. Nonneutralizing Antibodies to the CD4-Binding Site on the gp120 Subunit of Human Immunodeficiency Virus Type 1 Do Not Interfere with the Activity of a Neutralizing Antibody against the Same Site , 2003, Journal of Virology.
[58] Peter D. Kwong,et al. The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 , 2002, Journal of Virology.
[59] J. Sodroski,et al. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein , 1996, Journal of virology.
[60] D. Kabat,et al. Cooperation of Multiple CCR5 Coreceptors Is Required for Infections by Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.
[61] G Himmler,et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 , 1993, Journal of virology.
[62] J. Sodroski,et al. Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers , 2001, Journal of Virology.
[63] H. Katinger,et al. The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 , 2002, Journal of Virology.
[64] N. G. Wrigley. Electron microscopy of influenza virus. , 1979, British medical bulletin.
[65] G. Pauli,et al. Determination of the size of HIV using adenovirus type 2 as an internal length marker. , 1994, Journal of virological methods.
[66] N. Dimmock,et al. Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. , 1994, The Journal of general virology.
[67] D. Birx,et al. Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1. , 1995, AIDS research and human retroviruses.
[68] J. Sodroski,et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.
[69] Q. Sattentau,et al. Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation , 1996, The Journal of experimental medicine.
[70] K. Schønning,et al. Stoichiometry of Monoclonal Antibody Neutralization of T-Cell Line-Adapted Human Immunodeficiency Virus Type 1 , 1999, Journal of Virology.
[71] G. Shaw,et al. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions , 1987, Journal of virology.
[72] D. Burton,et al. Heterogeneity of Envelope Molecules Expressed on Primary Human Immunodeficiency Virus Type 1 Particles as Probed by the Binding of Neutralizing and Nonneutralizing Antibodies , 2003, Journal of Virology.
[73] S. Zolla-Pazner,et al. Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6 , 2001, Journal of Virology.
[74] J. Sodroski,et al. Effects of HIV type 1 envelope glycoprotein proteolytic processing on antigenicity. , 2003, AIDS research and human retroviruses.
[75] C. Barbas,et al. Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies , 1998, Journal of Virology.
[76] P. Earl,et al. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates , 1996, Journal of virology.
[77] S. Zolla-Pazner,et al. Neutralization Profiles of Primary Human Immunodeficiency Virus Type 1 Isolates in the Context of Coreceptor Usage , 1998, Journal of Virology.
[78] H. Katinger,et al. Neutralization Synergy of Human Immunodeficiency Virus Type 1 Primary Isolates by Cocktails of Broadly Neutralizing Antibodies , 2001, Journal of Virology.
[79] J. Bentz,et al. Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion. , 2000, Biophysical journal.
[80] N. Kaverin,et al. Formation of mixed hemagglutinin trimers in the course of double infection with influenza viruses belonging to different subtypes. , 1988, Virus research.
[81] A. Bourinbaiar,et al. The ratio of defective HIV-1 particles to replication-competent infectious virions. , 1994, Acta virologica.
[82] G. Melikyan,et al. The fusion kinetics of influenza hemagglutinin expressing cells to planar bilayer membranes is affected by HA density and host cell surface , 1995, The Journal of general physiology.
[83] J. Sodroski,et al. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody , 1991, Journal of virology.
[84] J. Moore,et al. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement , 1996, Journal of virology.
[85] J. Sodroski,et al. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys , 1997, Journal of virology.
[86] W. Koff,et al. Developing an AIDS Vaccine: Need, Uncertainty, Hope , 2004, Science.
[87] T. Stegmann,et al. Membrane Fusion Mechanisms: The Influenza Hemagglutinin Paradigm and its Implications for Intracellular Fusion , 2000, Traffic.